# Stentex to invest 9 billion rubles in coronary stent and catheter production in Russia

Stentex, a joint venture between Renova Group and Medtronic, is investing about 9 billion rubles in a production complex for coronary stents and catheters in Russia. At peak capacity in 2022, it plans to produce 250,000 stents per year and create about 700 jobs.

- Type: Investment
- Announced: 2017-04-27
- Where: Russia
- Value: $155.0M (9.00B RUB)
- Jobs: 700
- Starts operating: 2022
- Status: under construction
- Capacity: 250,000 stents per year
- Products: coronary stents, balloon catheters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Stentex](https://endata.com/companies/23837.md)
- [Medtronic plc](https://endata.com/companies/19071.md) (partner)
- [Renova](https://endata.com/companies/20332.md) (partner)

## Sources

- [kommersant.ru](https://www.kommersant.ru/doc/3280174), 2017-04-26: "При выходе на проектную мощность на предприятии будет создано около 700 квалифицированных рабочих мест в высокотехнологичном секторе медицинской промышленности."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.